RecallHawk
Class II Recall

Atellica CH Gamma-Glutamyl Transferase-IIn vitro diagnostic use in the quantitative determination of gamma-glutamyl tran

Siemens Healthcare Diagnostics, Inc.

Summary

The FDA issued a Class II for Atellica CH Gamma-Glutamyl Transferase-IIn vitro diagnostic use in the quantitat by Siemens Healthcare Diagnostics, Inc.. Reason: Potential for reagent carryover on the Atellica CH 930 resulting in a positive bias that could impact quality control (QC), patient samples, and calib.

Details

Source

Device Recall

External ID

Z-2473-2023

Action Date

2023-09-06

Status

Ongoing

Category

device

Product Description

Atellica CH Gamma-Glutamyl Transferase-IIn vitro diagnostic use in the quantitative determination of gamma-glutamyl transferase in human serum and plasma (lithium heparin Test Code: GGT Siemens Material Number (SMN): 11097597

Lot/Code Info: Unique Device Identification (UDI): 00630414596440 All Lot Numbers

Quantity Affected: 19544 units

Reason for Recall

Potential for reagent carryover on the Atellica CH 930 resulting in a positive bias that could impact quality control (QC), patient samples, and calibrator results with from Atellica¿CH Total Bilirubin_2 (TBil_2), Atellica¿ CH LDL Cholesterol (LDLC), Atellica¿ CH Gamma-Glutamyl Transferase (GGT) and Atellica¿ CH HDL Cholesterol (HDLC)

Distribution

US Nationwide - Worldwide Distribution Foreign: Taiwan Uruguay Vietnam

Type: Voluntary: Firm initiated

Recall Initiated: 2023-07-10

Context & Analysis

This is a Class II recall. Class II recalls indicate that use of or exposure to the product may cause temporary or medically reversible health consequences, or that the probability of serious consequences is remote.

This was one of 154 device recalls issued in the same week, part of 403 device-related FDA actions this month.

Siemens Healthcare Diagnostics, Inc. has 166 FDA actions in our database, including 142 recalls and 24 clearances.

Frequently Asked Questions

What is a Class II recall?

A Class II recall means the product may cause temporary or medically reversible adverse health consequences, or the probability of serious adverse consequences is remote. Consumers should discontinue use.

What should I do if I have this product?

Stop using the product. Check the product against the specific lot numbers or identifiers listed in the recall. Contact the manufacturer (Siemens Healthcare Diagnostics, Inc.) or your retailer for a refund or replacement. If you experienced adverse effects, report them to the FDA via MedWatch.

How often does Siemens Healthcare Diagnostics, Inc. have FDA actions?

Siemens Healthcare Diagnostics, Inc. has 166 FDA actions in our database, including 142 recalls and 24 device clearances.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "Z-2473-2023" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for device

Related Actions